A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes
Clinical trial NCT05996380 · UNKNOWN
Trial details
- NCT number
- NCT05996380
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-09
- Primary completion
- 2024-01-25
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.